心房颤动
医学
导管消融
重症监护医学
心律
心力衰竭
心脏病学
生活质量(医疗保健)
不利影响
内科学
护理部
作者
Michela Casella,Paolo Compagnucci,Manuel Conti,Umberto Falanga,Giovanni Volpato,Marco Fogante,Laura Cipolletta,Agostino Misiani,Silvano Molini,Andrea Giovagnoni,Antonio Dello Russo
出处
期刊:Minerva cardiology and angiology
[Edizioni Minerva Medica]
日期:2022-02-25
卷期号:70 (5): 628-638
被引量:2
标识
DOI:10.23736/s2724-5683.22.05859-8
摘要
Over the last 20 years, catheter ablation of atrial fibrillation (AF) has evolved from a research tool into a fundamental therapeutic measure, with the potential to improve symptoms, quality of life, and even risk of major adverse cardiac events (among patients with heart failure and a reduced ejection fraction). Notwithstanding the tremendous evolution in techniques and tools, risk of AF recurrences postablation is not negligible, and a comprehensive structured follow-up is highly needed to deliver optimal patient care. In this follow-up process, monitoring of heart rhythm is quintessential to detect recurrences, and may be accomplished by means of symptoms-triggered, intermittent, or continuous monitors. In recent years, the development and widespread adoption of implantable cardiac monitors, by allowing continuous long-term rhythm assessment, has surged to become the gold-standard strategy, both in research settings and in clinical practice. In this review, we both summarize the present state-of-the art on the detection of postablation AF recurrences and provide future perspectives on this emerging yet often neglected topic, aiming to give practical hints for evidence-based, personalized patient care.
科研通智能强力驱动
Strongly Powered by AbleSci AI